Eikon Therapeutics, Inc.
EIKN
$8.77
-$0.21-2.34%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -4.15% | -5.11% | |||
| Total Depreciation and Amortization | 0.16% | 4.04% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -39.20% | -0.46% | |||
| Change in Net Operating Assets | -146.95% | -83.39% | |||
| Cash from Operations | -115.23% | -129.66% | |||
| Capital Expenditure | -296.97% | 43.42% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -597.73% | -501.70% | |||
| Cash from Investing | -599.18% | -2,723.01% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 31,976.03% | -77.89% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 31,976.03% | 368,567.37% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 74,953.33% | 628.40% | |||